Real world experience with cladribine tablets in the management of relapsing multiple sclerosis in Qatar
CladT appeared to be effective and safe in our retrospective study, irrespective of prior treatments, consistent with other real world data that support the early use of CladT in the management of RRMS.
Authors
- Lina Okar (ORCID: https://orcid.org/0000-0001-7184-1235)
- Dirk Deleu
- Beatriz Canibaño
- Yahya Zakarya Baniamer
Institutions
- SSM Health Care (US)
- Saint Louis University (US)
- Hamad Medical Corporation (QA)
Publication Details
- Journal
- Clinical Neurology and Neurosurgery
- Published
- 2024-10-22
- DOI
- https://doi.org/10.1016/j.clineuro.2024.108615
- Citations
- 2
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- Merck KGaA